Skip to main content
Premium Trial:

Request an Annual Quote

EBI to Expand Facility to Support ELIXIR Infrastructure

Premium

The European Bioinformatics Institute officially broke ground this week for a new building on the Wellcome Trust Genome Campus in Hinxton, UK.

According to the EBI, the new building will house approximately 200 staff from EBI and the European Life-science Infrastructure for Biological Information, or ELIXIR.

The new facility is funded by a £75 million ($117.2 million) pledge from the UK government. Those funds were intended to support infrastructure development and the construction of a new hub for ELIXIR, a pan-European initiative funded by the European Commission and led by EBI (BI 12/9/2011).

Major support for the new building comes from the Biotechnology and Biological Sciences Research Council, the Medical Research Council, the Natural Environment Research Council, and the Wellcome Trust.

Filed under

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.